China SXT Pharmaceuticals, Inc. Long-Term Debt, Maturity, after Year Five
China SXT Pharmaceuticals, Inc. (SXTC) had Long-Term Debt, Maturity, after Year Five of CNY 15.57 thousand as of 2023-09-30, per its 6-K filed 2024-04-05.
Discontinued › Notes
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2024-04-05
- 2023-09-30: Long-Term Debt, Maturity, after Year Five 15.57K CNY.
- 2023-03-31: Long-Term Debt, Maturity, after Year Five 47.43K CNY.
CNY
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2023-09-30 | 15.57K CNY 6-K · filed 2024-04-05 |
| 2023-03-31 | 47.43K CNY 6-K · filed 2024-04-05 |
USD
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2023-09-30 | $2.13K 6-K · filed 2024-04-05 |
| 2023-03-31 | $6.55K 6-K · filed 2024-04-05 |